Ruxience 500 MG/50 ML vial 50ML
Ended Awarded Last action
- Contract number
- SPE2DR26F18YU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,093
Award facts
- Contract value 100% obligated
- $2,092.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,092.68 to AmerisourceBergen Drug Corp for the supply of Ruxience 500 mg/50 ml vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 5, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion comprehensive pharmaceutical supply vehicle designated as SPE2DX and running through December 2026. AmerisourceBergen is headquartered in Conshohocken, Pennsylvania, which also serves as the place of performance for this delivery order.
This delivery order is part of AmerisourceBergen's role as a critical pharmaceutical distributor within the Defense Health Agency supply chain, supporting military healthcare systems worldwide. Ruxience is a biosimilar medication used in cancer treatment and related therapeutic applications, reflecting the company's portfolio of specialty pharmaceuticals supplied through the DLA's global medical procurement network. The award demonstrates AmerisourceBergen's continued capability to meet federal medical supply requirements through competitive procurement processes, with pricing and delivery terms consistent with the company's extensive history of small to large-value pharmaceutical deliveries to defense healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F18YU?
SPE2DR26F18YU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F18YU worth?
The government has obligated $2,093 on SPE2DR26F18YU.
Is contract SPE2DR26F18YU an order under another contract?
Yes. SPE2DR26F18YU is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F18YU competed?
The extent of competition for SPE2DR26F18YU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award